Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence ofGVHDprophylaxis-Reference-Cited by-同舟云学术

Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence ofGVHDprophylaxis

Published:2019-05-28 Issue:5 Volume:186 Page:754-766
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Roy Denis Claude¹²,Lachance Sylvie¹²,Cohen Sandra¹²,Delisle Jean‐Sébastien¹²,Kiss Thomas¹²,Sauvageau Guy¹²,Busque Lambert¹²,Ahmad Imran¹²,Bernard Lea¹²,Bambace Nadia¹²,Boumédine Radia S.¹,Guertin Marie‐Claude³,Rezvani Katayoun⁴,Mielke Stephan⁵⁶,Perreault Claude¹²,Roy Jean¹²

Affiliation:

1. Division of Hematology‐Oncology/Stem Cell Transplantation Hôpital Maisonneuve‐Rosemont Research Center Montreal Canada

2. Department of Medicine Université de Montréal Montreal Canada

3. Department of Biostatistics Montreal Health Innovations Coordinating Center Montreal Canada

4. Department of Stem Cell Transplant and Cellular Therapy M.D. Anderson Cancer Center University of Texas Houston TX USA

5. Department of Internal Medicine II Center of Allogeneic Stem Cell Transplantation Wuerzburg University Medical Center University of Wuerzburg Wuerzburg Germany

6. Department of Laboratory Medicine CAST Karolinska Institute and University Hospital Stockholm Sweden

Funder

Kiadis Pharma

Fonds de Recherche du Québec - Santé

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15970

Reference53 articles.

1. Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016